XML 37 R27.htm IDEA: XBRL DOCUMENT v3.22.2.2
Note B - Summary of Significant Accounting Policies (Details Textual) - USD ($)
$ in Thousands
 3 Months Ended 9 Months Ended
May 15, 2022
May 07, 2021
Apr. 08, 2021
Mar. 02, 2021
Sep. 03, 2019
Mar. 20, 2012
Sep. 30, 2022
Sep. 30, 2021
Mar. 31, 2021
Sep. 30, 2022
Sep. 30, 2021
Dec. 31, 2021
Jul. 31, 2020
Revenue from Contract with Customer, Including Assessed Tax             $ 2,874 $ 1,965   $ 8,139 $ 26,068    
Income Taxes Receivable                       $ 100  
Accounts Receivable, Allowance for Credit Loss, Ending Balance             0     0   0  
Arimoclomol Purchase Agreement [Member]                          
Contract with Customer, Liability, Revenue Recognized             2,300     3,200      
Contract with Customer, Clawback Liability             1,200     1,700      
Asset Acquisition, Consideration Transferred, Estimated Reserve Liability $ 5,200           6,300     6,300      
Accounts Receivable, after Allowance for Credit Loss, Current, Total             4,900     4,900      
Consulting Services [Member]                          
Accounts Receivable, after Allowance for Credit Loss, Current, Total             600     600      
Consulting Services [Member]                          
Revenue from Contract with Customer, Including Assessed Tax             300     600 200    
Deferred Revenue, Total             0     0   0  
Accounts Receivable, after Allowance for Credit Loss, Current, Total                       100  
Income Taxes Receivable             700     700      
Other Receivables             400     400      
GPC Member | License [Member]                          
Revenue from Contract with Customer, Including Assessed Tax   $ 10,000 $ 10,000 $ 10,000 $ 10,000                
Revenue Recognition, Milestone Method, Revenue to be Recognized     $ 10,000   63,000                
Revenue Recognition, Milestone Method, Additional Revenue to be Recognized   $ 590,000     $ 420,000                
Contract with Customer, Liability, Revenue Recognized                 $ 10,000        
Deferred Revenue, Total             0     0   0  
Accounts Receivable, after Allowance for Credit Loss, Current, Total                       100  
Aquestive Therapeutics [Member] | License [Member]                          
Revenue from Contract with Customer, Including Assessed Tax             200     400 20,000    
Royalty Revenue, Percent           10.00%              
Royalty Expense                 $ 1,000        
Corium, Inc [Member]                          
Accounts Receivable, after Allowance for Credit Loss, Current, Total                       1,200  
Corium, Inc [Member] | Consulting Services [Member]                          
Revenue from Contract with Customer, Including Assessed Tax             0     3,500 5,900    
Deferred Revenue, Total             $ 0     $ 0   $ 400  
Consulting Agreement, Maximum Amount to be Received                         $ 15,600
Contract with Customer, Asset, after Allowance for Credit Loss, Total                         13,600
Consulting Agreement, Conditional Milestone Achievement to be Received               $ 2,000     $ 2,000   $ 2,000